Clinical Trial Update: Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of recombinant human C1 esterase inhibitor in healthy adults completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Recombinant human C1 esterase inhibitor (C1 esterase inhibitor (recombinant))

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema (HAE) | Phase 1 | Status: COMPLETED | Results posted: 2018-09-06